Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

LifeStance Health (LFST) Current Assets: 2021-2024

Historic Current Assets for LifeStance Health (LFST) over the last 4 years, with FY2024 value amounting to $312.5 million.

  • LifeStance Health's Current Assets rose 2555.81% to $360.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.3 billion, marking a year-over-year increase of 2916.57%. This contributed to the annual value of $312.5 million for FY2024, which is 3844.35% up from last year.
  • According to the latest figures from FY2024, LifeStance Health's Current Assets is $312.5 million, which was up 3844.35% from $225.7 million recorded in FY2023.
  • In the past 5 years, LifeStance Health's Current Assets registered a high of $312.5 million during FY2024, and its lowest value of $225.7 million during FY2023.
  • For the 4-year period, LifeStance Health's Current Assets averaged around $259.5 million, with its median value being $249.9 million (2021).
  • As far as peak fluctuations go, LifeStance Health's Current Assets plummeted by 1249.32% in 2022, and later skyrocketed by 3844.35% in 2024.
  • LifeStance Health's Current Assets (Annual) stood at $266.5 million in 2021, then fell by 12.49% to $233.2 million in 2022, then dropped by 3.21% to $225.7 million in 2023, then soared by 38.44% to $312.5 million in 2024.
  • Its Current Assets was $312.5 million in FY2024, compared to $225.7 million in FY2023 and $233.2 million in FY2022.